deficiencia 1 518 1 9601,	
galactosemia) 1 518 1 9599,	
galactosa 2 518 2 9592,9596,	
glucosa 1 518 1 9589,	
malabsorción 2 518 2 9587,9590,	
isomaltasa 1 518 1 9582,	
déficit 2 518 2 9577,9580,	
contienen 1 518 1 9566,	
(hidroxi-metil-glutaril)-CoA 1 518 1 9215,	
presentar 1 518 1 8853,	
debería 1 518 1 8158,	
17 1 518 1 7959,	
recomendado 1 518 1 7927,	
confirmar 1 518 1 7917,	
formulaciones 1 518 1 7909,	
ó 1 518 1 7901,	
formulación 2 518 2 7877,7884,	
cambiados 1 518 1 7874,	
(n=167) 1 518 1 7544,	
proporcionaron 1 518 1 7535,	
partido 1 518 1 7108,	
masticado 1 518 1 7106,	
machacado 1 518 1 7105,	
haberse 1 518 1 7104,	
determinado 1 518 1 7097,	
" 1 518 1 7000,	
mg"" 1 518 1 6999,	
cara 1 518 1 6996,	
grabado 1 518 1 6993,	
lleva 1 518 1 6992,	
blanco 1 518 1 6990,	
color 1 518 1 6989,	
triangular 1 518 1 6987,	
Comprimido 1 518 1 6985,	
recubierto 2 518 2 6984,6986,	
comprimido 1 518 1 6962,	
recubiertos 1 518 1 6955,	
comprimidos 6 518 6 6954,7102,7521,7886,7915,9563,	
europa 1 518 1 6945,	
emea 1 518 1 6944,	
//www 1 518 1 6943,	
http 1 518 1 6942,	
Europea 1 518 1 6938,	
web 1 518 1 6934,	
página 1 518 1 6933,	
detallada 1 518 1 6925,	
TEXTO 1 518 1 6922,	
2006 1 518 1 6915,	
15 1 518 1 6911,	
revalidación 1 518 1 6910,	
última 1 518 1 6909,	
2001 1 518 1 6905,	
autorización 1 518 1 6900,	
Fecha 2 518 2 6897,6906,	
AUTORIZACIÓN/RENOVACIÓN 1 518 1 6893,	
PRIMERA 1 518 1 6892,	
FECHA 2 518 2 6889,6917,	
EU/1/01/171/001 1 518 1 6887,	
NÚMERO(S) 1 518 1 6882,	
Unido 1 518 1 6880,	
Maidenhead 1 518 1 6875,	
South 1 518 1 6873,	
Lane 1 518 1 6872,	
Ltd 1 518 1 6870,	
Europa 1 518 1 6869,	
	Wyeth 1 518 1 6868,	
COMERCIALIZACIÓN 2 518 2 6867,6886,	
AUTORIZACIÓN 3 518 3 6865,6884,6896,	
LA 4 518 4 6864,6891,6895,6919,	
ml) 1 518 1 6847,	
adicional 1 518 1 6843,	
recipiente 1 518 1 6839,	
Rellenar 1 518 1 6837,	
beber 2 518 2 6833,6857,	
vigorosamente 2 518 2 6831,6855,	
Agitar 1 518 1 6830,	
incluido 1 518 1 6825,	
líquidos 1 518 1 6824,	
vaso 1 518 1 6794,	
correcta 1 518 1 6786,	
Vaciar 1 518 1 6783,	
prescrita 1 518 1 6777,	
extraer 1 518 1 6774,	
dosificadora 1 518 1 6770,	
Instrucciones 1 518 1 6762,	
locales 1 518 1 6761,	
contacto 1 518 1 6751,	
hayan 1 518 1 6748,	
manipulaciones 1 518 1 6735,	
topacio 1 518 1 6712,	
vidrio 2 518 2 6711,6796,	
Botellas 1 518 1 6709,	
Naturaleza 1 518 1 6704,	
horas) 1 518 1 6701,	
corto 1 518 1 6696,	
botellas 1 518 1 6687,	
protegerlo 1 518 1 6675,	
original 1 518 1 6673,	
botella 2 518 2 6672,6782,	
8º 1 518 1 6667,	
C 2 518 2 6665,6693,	
2º 1 518 1 6664,	
(entre 1 518 1 6663,	
Conservar 2 518 2 6660,6669,	
conservación 1 518 1 6659,	
6) 1 518 1 6648,	
Taplow 1 518 1 6874,	
25º 2 518 2 6639,6692,	
sobrepasar 1 518 1 6637,	
ambiente 2 518 2 6634,6690,	
temperatura 2 518 2 6633,6689,	
(a 1 518 1 6632,	
dosificadoras 1 518 1 6629,	
abierto 1 518 1 6623,	
Frasco 1 518 1 6622,	
validez 1 518 1 6619,	
dilución 3 518 3 6607,6644,6819,	
plástico 3 518 3 6604,6726,6798,	
inmediatamente 2 518 2 6595,6653,	
instrucciones 1 518 1 6592,	
considerar 1 518 1 6590,	
importante 1 518 1 6589,	
vinilo 1 518 1 6583,	
Etilhexil)ftalato 1 518 1 6576,	
Precauciones 3 518 3 6554,6656,6729,	
diluido 1 518 1 6535,	
ascorbilo) 1 518 1 6527,	
palmitato 1 518 1 6525,	
soja 1 518 1 6523,	
grasos 1 518 1 6521,	
ácidos 1 518 1 6520,	
5%) 1 518 1 6519,	
5% 1 518 1 6516,	
etanol 1 518 1 6514,	
diglicéridos 1 518 1 6513,	
monoglicéridos 1 518 1 6512,	
propilenglicol 1 518 1 6511,	
PG 1 518 1 6509,	
Phosal 1 518 1 6507,	
80 2 518 2 6506,6566,	
Polisorbato 1 518 1 6505,	
Lista 1 518 1 6502,	
FARMACÉUTICOS 1 518 1 6499,	
Ver 2 518 2 6493,6553,	
esquelética) 1 518 1 6492,	
osificación 1 518 1 6491,	
retrasos 1 518 1 6487,	
fetos 1 518 1 6485,	
mortalidad 1 518 1 6478,	
manifestó 1 518 1 6476,	
embrio/fetotoxicidad 1 518 1 6473,	
provocó 1 518 1 6472,	
monos 1 518 1 6468,	
gigantes 1 518 1 6457,	
materiales 1 518 1 6746,	
atrofia 1 518 1 6453,	
histológicas 1 518 1 6450,	
espermatozoides 1 518 1 6438,	
recuentos 1 518 1 6436,	
parcialmente 1 518 1 6432,	
13 1 518 1 6427,	
macho 1 518 1 6420,	
reproducción 1 518 1 6410,	
importancia 1 518 1 6401,	
consideran 1 518 1 6399,	
normalmente 1 518 1 6397,	
luteinizante 1 518 1 6395,	
hormona 1 518 1 6394,	
especie 1 518 1 6388,	
dependiente 1 518 1 6385,	
indicativos 1 518 1 6381,	
probablemente 1 518 1 6379,	
testiculares 1 518 1 6378,	
intersticiales 1 518 1 6377,	
adenomas 1 518 1 6375,	
crónica 1 518 1 6371,	
relacionados 1 518 1 6367,	
lesiones 2 518 2 6359,6449,	
observados 1 518 1 6348,	
crónico 1 518 1 6341,	
secundarios 1 518 1 6337,	
(linfomas) 1 518 1 6336,	
esperarse 1 518 1 6334,	
conocido 1 518 1 6331,	
vasos 1 518 1 6801,	
Es 1 518 1 6330,	
hembra) 1 518 1 6329,	
granulocítica 1 518 1 6327,	
leucemia 1 518 1 6326,	
adenoma 1 518 1 6318,	
hembras) 1 518 1 6317,	
machos 1 518 1 6315,	
(ratones 3 518 3 6314,6322,6328,	
linfomas 1 518 1 6313,	
incidencias 1 518 1 6311,	
ratones 2 518 2 6303,6356,	
cabo 1 518 1 6301,	
llevados 1 518 1 6299,	
carcinogenicidad 1 518 1 6298,	
Estudios 1 518 1 6296,	
micronúcleos 1 518 1 6293,	
ratón 2 518 2 6285,6295,	
hámster 1 518 1 6271,	
ovario 1 518 1 6269,	
aberración 1 518 1 6264,	
bacterias 1 518 1 6257,	
inversa 1 518 1 6255,	
mutación 2 518 2 6254,6279,	
mutagénico 1 518 1 6250,	
pulmonar 1 518 1 6246,	
fosfolipidosis 1 518 1 6245,	
hematopoyesis 1 518 1 6242,	
cromosómica 1 518 1 6265,	
óseas 1 518 1 6241,	
callosidades 1 518 1 6240,	
tubular 2 518 2 6232,6454,	
degeneración 1 518 1 6231,	
islotes 1 518 1 6227,	
repercusión 1 518 1 6217,	
detectadas 1 518 1 6203,	
preclínicos 1 518 1 6191,	
Datos 1 518 1 6190,	
diálisis) 1 518 1 6187,	
(pacientes 1 518 1 6184,	
ausente 1 518 1 6183,	
varía 1 518 1 6179,	
semividaobservada 1 518 1 6150,	
67 1 518 1 6134,	
170 1 518 1 6123,	
43 1 518 1 6077,	
61 1 518 1 6073,	
ulceración 1 518 1 6236,	
t1/2 2 518 2 6068,6114,	
B) 1 518 1 6060,	
Child-Pugh 2 518 2 6057,6105,	
(Clasificación 2 518 2 6055,6103,	
moderada 1 518 1 6054,	
individuos 1 518 1 6040,	
adaptador 1 518 1 6719,	
gran 1 518 1 6036,	
mayores 2 518 2 6025,7531,	
ml/h/kg) 3 518 3 6020,6027,6033,	
(580 1 518 1 6019,	
menor 1 518 1 6017,	
peso 2 518 2 6010,6482,	
normalizado 1 518 1 6007,	
CL/F 2 518 2 6006,6084,	
50 2 518 2 5975,6508,	
- 1 518 1 5974,	
(con 2 518 2 5970,6486,	
respecto 1 518 1 5942,	
diluir 1 518 1 5936,	
agua 4 518 4 5934,6548,6812,6849,	
(AUC) 1 518 1 5912,	
(tmáx 1 518 1 5900,	
(Cmáx 1 518 1 5884,	
34 1 518 1 5874,	
produjo 1 518 1 5870,	
líquido 2 518 2 5867,6544,	
características 1 518 1 5862,	
observaron 2 518 2 6430,6440,	
alteró 1 518 1 5860,	
contenido 2 518 2 5857,6706,	
alimentación 1 518 1 5854,	
responderían 1 518 1 5807,	
pequeña 1 518 1 5781,	
excretó 1 518 1 5779,	
heces 1 518 1 5775,	
%) 2 518 2 5770,5785,	
(91 1 518 1 5768,	
recuperó 1 518 1 5764,	
[14C]sirolimus 1 518 1 5759,	
90 1 518 1 5747,	
constituye 1 518 1 5744,	
componente 1 518 1 5737,	
hidroxilo 1 518 1 5730,	
210 1 518 1 6119,	
principales 1 518 1 5728,	
siete 1 518 1 5726,	
identificaron 1 518 1 5725,	
hidroxilación 1 518 1 5720,	
O-desmetilación 1 518 1 5718,	
metaboliza 1 518 1 5715,	
IIIA 1 518 1 5707,	
diversas 1 518 1 6173,	
n=219) 1 518 1 5687,	
22 1 518 1 5679,	
grasa 1 518 1 5859,	
cromatográfico; 2 518 2 5662,5686,	
expresado 2 518 2 5657,5681,	
ng/mL 1 518 1 5656,	
LC-SM/SM) 1 518 1 5609,	
partir 2 518 2 5603,6579,	
calculados 1 518 1 5601,	
ml/h/kg 1 518 1 5599,	
72 1 518 1 5598,	
pediátricos 3 518 3 5966,6015,6024,	
182 1 518 1 5596,	
ng·h/ml 1 518 1 5594,	
70 1 518 1 5593,	
158 1 518 1 5591,	
AUCt 1 518 1 5589,	
ss 3 518 3 5574,5582,5590,	
III 3 518 3 5571,5646,6714,	
clínico 2 518 2 5568,6221,	
diarias 1 518 1 5558,	
Rapamune) 1 518 1 5552,	
(4 2 518 2 5548,5652,	
19 2 518 2 5539,9122,	
Cl/F 1 518 1 6130,	
farmacocinéticos 2 518 2 5534,6167,	
celulares 2 518 2 5528,6376,	
elementos 1 518 1 5527,	
ampliamente 2 518 2 5524,5716,	
distribuye 1 518 1 5523,	
(450 1 518 1 6026,	
alcanzaron 1 518 1 5503,	
medias 1 518 1 5497,	
corta 1 518 1 5493,	
embargo 1 518 1 5487,	
Sin 1 518 1 5486,	
h 2 518 2 5485,5588,	
16 1 518 1 5484,	
repetida 1 518 1 5454,	
14 3 518 3 5449,5674,6901,	
(Sandimmun) 1 518 1 5444,	
sistémica 1 518 1 5434,	
disponibilidad 1 518 1 5433,	
únicas 1 518 1 5417,	
hora 1 518 1 5410,	
pico 3 518 3 5407,5879,5899,	
daclizumab 1 518 1 5384,	
evitarse 1 518 1 5963,	
utilizó 1 518 1 5377,	
mejor 1 518 1 5357,	
numéricamente 1 518 1 5325,	
antagonista 2 518 2 5308,5343,	
(MMF) 1 518 1 5304,	
multicéntricos 1 518 1 5291,	
éste 1 518 1 5285,	
vio 1 518 1 5275,	
correspondiente 1 518 1 5245,	
convertidos 1 518 1 5238,	
normal 2 518 2 5223,6181,	
urinaria 1 518 1 5222,	
9%) 1 518 1 5204,	
melanóticas 1 518 1 5177,	
comparados 1 518 1 5136,	
continuó 2 518 2 5133,5194,	
orina 2 518 2 5124,5787,	
ratios 1 518 1 5121,	
dieron 1 518 1 5087,	
emergentes 1 518 1 5081,	
mejoró 1 518 1 5057,	
eventos 1 518 1 5036,	
<40 2 518 2 5028,5112,	
cuya 3 518 3 5025,5048,5109,	
estrato 3 518 3 5022,5045,5106,	
trasplante) 1 518 1 5003,	
evaluó 1 518 1 4976,	
mL/min) 1 518 1 4974,	
MMF 1 518 1 5339,	
(20-40 1 518 1 4970,	
fracturas 1 518 1 6238,	
inicio 1 518 1 4967,	
FG 6 518 6 4964,5026,5049,5110,5214,5225,	
aleatorizado 1 518 1 4955,	
Mediante 1 518 1 4952,	
retrasó 1 518 1 4950,	
suceso 1 518 1 4948,	
>40 3 518 3 4973,5051,5215,	
carcinoma 2 518 2 4939,6321,	
(8 2 518 2 4931,5676,	
continuaron 3 518 3 4911,5140,5249,	
cohorte 2 518 2 4907,4919,	
neoplasias 2 518 2 4898,5174,	
quitar 1 518 1 4881,	
sanguínea 1 518 1 4868,	
presión 1 518 1 4867,	
creciente 1 518 1 4852,	
análisis 1 518 1 4840,	
elevada 2 518 2 4813,4904,	
8% 3 518 3 4777,4935,5201,	
(9 1 518 1 4776,	
pancreáticas 1 518 1 6230,	
comparado 2 518 2 4759,5189,	
biopsia 1 518 1 4750,	
confirmado 1 518 1 4748,	
primer 2 518 2 4743,4947,	
seguimiento) 1 518 1 4735,	
seguido 2 518 2 4712,4820,	
favor 1 518 1 4707,	
estadísticamente 1 518 1 4699,	
hubo 2 518 2 4696,5611,	
48 2 518 2 4694,4806,	
grupos 2 518 2 4691,4787,	
similar 1 518 1 4688,	
supervivencia 3 518 3 4681,4703,4856,	
recomiendan 1 518 1 4667,	
inadecuada 1 518 1 4632,	
micromoles/l 1 518 1 4625,	
>400 1 518 1 4624,	
""RAPAMUNE 1 518 1 6997,	
Banff 1 518 1 4612,	
Grado 1 518 1 4610,	
agudos 1 518 1 4608,	
episodios 1 518 1 4605,	
sobrevivieron 1 518 1 4586,	
anteriores 1 518 1 4585,	
injertos 1 518 1 4584,	
proteína/creatinina 1 518 1 5122,	
cuyos 1 518 1 4583,	
re-trasplante 1 518 1 4582,	
muerto 1 518 1 4576,	
donante 1 518 1 4573,	
aloinjerto 1 518 1 4569,	
incluyó 2 518 2 4564,5010,	
ciclosporina-mantenimiento 2 518 2 4560,4661,	
fase 3 518 3 4555,5570,5645,	
presentaron 1 518 1 4544,	
estudiaron 2 518 2 4541,4651,	
(S/P) 1 518 1 5516,	
Ensayos 1 518 1 4538,	
aloinjertos 2 518 2 4537,5425,	
mediadas 1 518 1 4527,	
suprimiendo 1 518 1 4525,	
B 1 518 1 4524,	
directo 1 518 1 4515,	
linfocitos 1 518 1 4502,	
neto 1 518 1 4493,	
resulta 1 518 1 4479,	
ciclo 1 518 1 4473,	
progresión 1 518 1 4471,	
crítica 1 518 1 4468,	
quinasa 1 518 1 4467,	
(mTOR) 1 518 1 4465,	
mamíferos 1 518 1 4464,	
Rapamicina 1 518 1 4462,	
Diana 1 518 1 4459,	
Molécula 1 518 1 4458,	
12-sirolimus 1 518 1 4452,	
FKPB 1 518 1 4451,	
complejo 1 518 1 4450,	
FKPB-12 1 518 1 4446,	
	"Comprimido 1 518 1 6983,	
une 1 518 1 4440,	
experimental 1 518 1 4435,	
di-(2- 1 518 1 6575,	
fertilidad 1 518 1 6417,	
± 5 518 5 5483,5577,5585,5592,5597,	
evidencia 1 518 1 4434,	
mecanismo 1 518 1 4422,	
demuestran 1 518 1 4414,	
Ciertos 1 518 1 4412,	
independientes 1 518 1 4409,	
dependientes 2 518 2 4407,4616,	
intracelulares 1 518 1 4406,	
señales 2 518 2 4405,4490,	
(mínimo 1 518 1 6844,	
transducción 2 518 2 4403,4488,	
citosólica 1 518 1 4444,	
estímulos 1 518 1 4397,	
inducida 1 518 1 4391,	
T 2 518 2 4390,4522,	
activación 4 518 4 4386,4455,4499,4518,	
A10 1 518 1 4382,	
ATC 1 518 1 4380,	
Código 1 518 1 4379,	
selectivos 1 518 1 4378,	
farmacoterapéutico 1 518 1 4375,	
Grupo 1 518 1 4374,	
farmacodinámicas 1 518 1 4373,	
conservar 1 518 1 6685,	
Propiedades 2 518 2 4372,5387,	
ESTE 1 518 1 4368,	
PROPIEDADES 1 518 1 4365,	
cantidad 4 518 4 4361,5782,6776,6785,	
dializable 1 518 1 4358,	
será 1 518 1 4357,	
eritrocitos 1 518 1 4346,	
alta 3 518 3 4342,4741,5229,	
acuosa 1 518 1 4338,	
baja 3 518 3 4336,4871,5181,	
soporte 1 518 1 4331,	
sobredosificación 1 518 1 4312,	
general 1 518 1 4307,	
150 1 518 1 4302,	
ingestión 1 518 1 4300,	
manipulación 1 518 1 6765,	
auricular 1 518 1 4296,	
unión 1 518 1 4343,	
episodio 2 518 2 4293,4744,	
experimentó 1 518 1 4291,	
paciente 3 518 3 4290,4686,6683,	
Un 1 518 1 4289,	
sobredosis 2 518 2 4288,4326,	
Sobredosis 1 518 1 4281,	
meses) 1 518 1 4278,	
nevera 1 518 1 6662,	
36 5 518 5 4277,4678,4805,4845,5518,	
post-transplante 1 518 1 4276,	
mediana 3 518 3 4273,4943,5118,	
60 5 518 5 4272,4808,4893,6716,6809,	
brazo 3 518 3 4265,5279,5360,	
agudo 5 518 5 4257,4747,5065,5260,5317,	
serios 1 518 1 4253,	
ml/min 1 518 1 4241,	
basal 1 518 1 4236,	
filtrado 1 518 1 4234,	
90) 1 518 1 4229,	
subgrupo 4 518 4 4224,5207,5244,5286,	
cesó 1 518 1 4219,	
ng/ml) 1 518 1 4209,	
­ 1 518 1 4207,	
(niveles 1 518 1 4203,	
evalúa 1 518 1 4189,	
marcha 1 518 1 4187,	
SHU/PTT/MAT 1 518 1 4176,	
biliar) 1 518 1 4107,	
ureteral 1 518 1 4106,	
conductos 1 518 1 4104,	
vascular 1 518 1 4101,	
ejemplo 2 518 2 4098,6452,	
(por 2 518 2 4097,6451,	
quirúrgica 1 518 1 4093,	
fascial 1 518 1 4091,	
cirugía 1 518 1 4086,	
anormal 1 518 1 4082,	
proporcionalmente 1 518 1 4070,	
suspensión 1 518 1 4064,	
resolvió 1 518 1 4055,	
inmunosupresoras 1 518 1 4044,	
terapias 1 518 1 4043,	
pulmonar) 1 518 1 4035,	
fibrosis 1 518 1 4034,	
idiopática) 1 518 1 4032,	
(BONO 1 518 1 4031,	
organizativa 1 518 1 4030,	
idiopática 1 518 1 4027,	
obliterante 1 518 1 4026,	
bronquiolitis 1 518 1 4025,	
raramente 1 518 1 4024,	
neumonitis 1 518 1 4022,	
intersticial 2 518 2 4016,4053,	
aparecido 1 518 1 4012,	
Han 1 518 1 4011,	
mortal 1 518 1 4004,	
necrosis 1 518 1 4002,	
raros 2 518 2 4000,6352,	
hepatotoxicidad 1 518 1 3983,	
particular 1 518 1 3970,	
REVISIÓN 1 518 1 6920,	
complementarias 1 518 1 3956,	
etiología 1 518 1 4018,	
Exploraciones 1 518 1 3955,	
lugar 1 518 1 3952,	
generales 2 518 2 3947,4332,	
urinarios 1 518 1 3945,	
renales 2 518 2 3943,5426,	
musculoesqueléticos 1 518 1 3937,	
subcutáneo 1 518 1 3935,	
tejido 2 518 2 3934,3940,	
Erupción 1 518 1 3931,	
Acné 1 518 1 3930,	
mediastínicos 1 518 1 3923,	
glomerular) 1 518 1 5984,	
torácicos 1 518 1 3921,	
respiratorios 2 518 2 3920,4105,	
vasculares 1 518 1 3918,	
cardiacos 1 518 1 3916,	
hepatobiliares 1 518 1 3903,	
Trastornos 12 518 12 3894,3902,3904,3908,3915,3917,3919,3924,3926,3936,3942,3946,	
pólipos) 1 518 1 3893,	
quistes 1 518 1 3891,	
(incl 1 518 1 3890,	
especificadas 1 518 1 3889,	
malignas 1 518 1 3886,	
agitar 1 518 1 6854,	
benignas 1 518 1 3885,	
realizará 1 518 1 6755,	
Neoplasias 1 518 1 3884,	
Linfoma 1 518 1 3882,	
interrumpió 1 518 1 5017,	
Cáncer 1 518 1 3879,	
infestaciones 1 518 1 3877,	
Infecciones 1 518 1 3875,	
1/10 1 518 1 3872,	
000 2 518 2 3869,3873,	
1/1 1 518 1 3868,	
(parámetros 1 518 1 5600,	
experimentaron 1 518 1 4604,	
< 3 518 3 3865,3870,3874,	
1/100 1 518 1 3864,	
( 4 518 4 3861,3863,3867,3871,	
sistemas 1 518 1 3860,	
Raras 1 518 1 3857,	
Frecuentes 1 518 1 3854,	
Muy 1 518 1 3852,	
Clasificación 1 518 1 3850,	
administrando 1 518 1 3842,	
regímenes 1 518 1 3839,	
razonable 1 518 1 3822,	
sospecha 2 518 2 3821,4353,	
existe 1 518 1 3817,	
Sólo 1 518 1 3809,	
gravedad 1 518 1 3802,	
decreciente 1 518 1 3800,	
orden 1 518 1 3799,	
comercialización 1 518 1 3792,	
post- 1 518 1 3791,	
realizados 1 518 1 3786,	
últimos 1 518 1 3783,	
frecuencia 3 518 3 3778,3808,5090,	
clasificación 1 518 1 3772,	
enumeran 2 518 2 3797,3811,	
resumen 1 518 1 3764,	
tabla 1 518 1 3762,	
siguiente 1 518 1 3761,	
conforme 2 518 2 3751,3988,	
incrementarse 2 518 2 3750,3987,	
(LDH) 1 518 1 3740,	
deshidrogenasa 1 518 1 3739,	
lactato 1 518 1 3738,	
diarrea 1 518 1 3733,	
artralgia 1 518 1 3731,	
abdominal 1 518 1 3727,	
hipertrigliceridemia 1 518 1 3725,	
incrementada 1 518 1 5276,	
hiperglucemia 1 518 1 3724,	
hipercolesterolemia 1 518 1 3723,	
urinario 1 518 1 3722,	
intolerancia 2 518 2 9583,9593,	
tracto 1 518 1 3721,	
plasmáticas 1 518 1 4349,	
anemia 1 518 1 3716,	
>10% 1 518 1 3709,	
01 1 518 1 5584,	
(ocurren 1 518 1 3707,	
notificadas 1 518 1 3706,	
avance 1 518 1 6277,	
frecuentes 3 518 3 3705,3853,3856,	
Reacciones 1 518 1 3699,	
realizado 1 518 1 3684,	
máquinas 2 518 2 3680,3696,	
utilizar 2 518 2 3679,3695,	
conducir 2 518 2 3677,3693,	
capacidad 2 518 2 3675,3691,	
Efectos 1 518 1 3672,	
(versección 1 518 1 3667,	
interrumpir 2 518 2 3665,4135,	
reversibles 3 518 3 3663,4133,6433,	
esperma 2 518 2 3646,4116,	
alteraciones 3 518 3 3641,3949,4111,	
interrumpida 1 518 1 3634,	
adversas 7 518 7 3627,3700,3703,3767,3795,5080,6196,	
provocar 1 518 1 3625,	
L04A 1 518 1 4381,	
potencial 1 518 1 3621,	
vacuolación 1 518 1 6225,	
humana 2 518 2 3618,5742,	
excreta 1 518 1 3614,	
radioactividad 2 518 2 3604,5773,	
detectó 1 518 1 3603,	
lactantes 2 518 2 3601,3629,	
ratas 7 518 7 3600,6306,6373,6419,6425,6462,6470,	
ulcerosas 1 518 1 6361,	
Después 5 518 5 3592,4782,5389,5753,6641,	
eficaz 1 518 1 3591,	
claramente 1 518 1 3568,	
embarazo 1 518 1 3562,	
humanos 1 518 1 3555,	
jeringa 3 518 3 6721,6769,6791,	
seres 1 518 1 3554,	
Berkshire 1 518 1 6876,	
desconoce 1 518 1 3550,	
utilizarse 3 518 3 3559,3587,6822,	
3) 3 518 3 3548,3669,4140,	
reproductiva 1 518 1 3544,	
toxicidad 2 518 2 3543,6407,	
mostrado 1 518 1 3542,	
estudios 6 518 6 3538,3685,4413,5289,5375,6405,	
embarazadas 1 518 1 3536,	
cutáneas 3 518 3 4900,5175,6360,	
mujeres 1 518 1 3535,	
utilización 1 518 1 3531,	
suficientes 1 518 1 3528,	
existen 1 518 1 3526,	
lactancia 2 518 2 3524,3631,	
Embarazo 1 518 1 3522,	
trimetoprim/sulfametoxazol 1 518 1 3519,	
prednisolona 1 518 1 3517,	
nifedipino 1 518 1 3516,	
metilprednisolona 1 518 1 3515,	
glibenclamida 1 518 1 3514,	
digoxina 1 518 1 3513,	
atorvastatina 1 518 1 3512,	
aciclovir 1 518 1 3511,	
significativas 1 518 1 3502,	
observado 3 518 3 3498,3640,4110,	
metoclopramida 1 518 1 3494,	
cisaprida 1 518 1 3492,	
gastrointestinales 2 518 2 3490,3925,	
polisorbato 1 518 1 6565,	
procinéticos 1 518 1 3489,	
observarse 1 518 1 3484,	
Pueden 1 518 1 3483,	
evitado 1 518 1 3482,	
mediado 2 518 2 3474,5955,	
afecta 2 518 2 3471,5952,	
pomelo 4 518 4 3470,5951,6539,6829,	
intestinales 1 518 1 3460,	
células 7 518 7 3459,4389,4521,6229,6267,6281,6456,	
disminuir 1 518 1 3453,	
gp-P 1 518 1 3451,	
reciben 1 518 1 3443,	
observadas 2 518 2 3439,6198,	
elevadas 1 518 1 3436,	
producir 1 518 1 3430,	
sacarosa 1 518 1 9567,	
desequilibrio 1 518 1 5033,	
necesarias 1 518 1 3428,	
isoenzimas 1 518 1 3421,	
1/10) 2 518 2 3862,3866,	
actividad 2 518 2 3418,5751,	
inhiba 1 518 1 3416,	
vivo 3 518 3 3412,4574,6291,	
espera 1 518 1 3409,	
CYP3A4/5 1 518 1 3406,	
CYP2C19 1 518 1 3403,	
CYP2C9 1 518 1 3402,	
P450 2 518 2 3401,5706,	
microsomal 1 518 1 3400,	
hepático 1 518 1 3399,	
citocromo 2 518 2 3398,5705,	
vitro 2 518 2 3396,6259,	
in 4 518 4 3395,3411,6258,6290,	
fenitoína) 1 518 1 3391,	
fenobarbital 1 518 1 3390,	
anticonvulsivos 1 518 1 3388,	
perforatum) 1 518 1 3387,	
Juan 1 518 1 3385,	
San 1 518 1 3384,	
Hierba 1 518 1 3382,	
proteasa) 1 518 1 3363,	
cimetidina 1 518 1 3359,	
rutas 1 518 1 4485,	
bromocriptina 1 518 1 3358,	
troleandomicina; 1 518 1 3355,	
antibióticos 1 518 1 3354,	
antifúngicos 1 518 1 3351,	
(DEHP) 1 518 1 6577,	
nicardipina; 1 518 1 3349,	
calcio 2 518 2 3348,4411,	
bloqueantes 1 518 1 3343,	
ej 3 518 3 3342,3381,9598,	
(p 3 518 3 3341,3380,9597,	
débiles 1 518 1 3326,	
moderados 1 518 1 3324,	
gastrointestinal 1 518 1 6237,	
(1 2 518 2 5200,6515,	
posibles 1 518 1 3321,	
plazo 1 518 1 3316,	
afectar 1 518 1 3305,	
decidió 1 518 1 4880,	
puedan 1 518 1 3304,	
posibilidad 1 518 1 3297,	
interacciones 4 518 4 3289,3320,3485,3499,	
resultados 4 518 4 3270,3292,5606,7536,	
Aunque 2 518 2 3268,3392,	
linfático 1 518 1 3901,	
etinilestradiol 1 518 1 3267,	
norgestrel/0 1 518 1 3263,	
0 3 518 3 3259,5653,5677,	
significativa 5 518 5 3255,4362,4700,4790,5614,	
(6-120 1 518 1 4999,	
orales 2 518 2 3247,5478,	
específica 1 518 1 4445,	
eritromicina 2 518 2 3167,3215,	
neumopatía 2 518 2 4015,4052,	
Eritromicina 1 518 1 3157,	
medicaciones 2 518 2 3156,3245,	
farmacocinéticas 4 518 4 3290,3486,3500,5388,	
ambas 2 518 2 3155,3244,	
adecuadas 2 518 2 3151,3242,	
crónicas 1 518 1 6362,	
reducciones 4 518 4 3150,3239,6431,6441,	
t 3 518 3 3135,3186,3209,	
S-(-) 1 518 1 3128,	
plasma 3 518 3 3127,3218,5515,	
Tanto 1 518 1 3118,	
fármacos 2 518 2 3096,3183,	
0PH 1 518 1 6878,	
verapamilo 2 518 2 3080,3125,	
Verapamilo 1 518 1 3070,	
desmetildiltiazem 1 518 1 3049,	
desacetildiltiazem 1 518 1 3047,	
metabolitos 2 518 2 3046,5727,	
envase 2 518 2 6603,6708,	
aumentaron 8 518 8 3026,3108,3129,3196,3219,6071,6117,6357,	
pacientes) 1 518 1 3712,	
tmáx 1 518 1 3023,	
acné 1 518 1 3732,	
diltiazem 3 518 3 3012,3042,3053,	
120 2 518 2 3009,6846,	
simultánea 2 518 2 2999,5441,	
marzo 2 518 2 6903,6913,	
11 3 518 3 2976,5655,5994,	
incrementa 2 518 2 2965,3990,	
días) 1 518 1 2961,	
100 1 518 1 2954,	
n=226) 1 518 1 5663,	
(400 1 518 1 2946,	
múltiples 3 518 3 2941,3077,3164,	
(una 1 518 1 2931,	
Voriconazol 1 518 1 2919,	
9 3 518 3 2903,4280,6888,	
4; 2 518 2 2898,3028,	
Tmáx 1 518 1 2891,	
refleja 1 518 1 2882,	
(inhibidor 5 518 5 2855,2920,2993,3071,3158,	
Ketoconazol 1 518 1 2854,	
co- 1 518 1 2844,	
pesos 1 518 1 6444,	
71 1 518 1 2837,	
deseados 1 518 1 4204,	
% 14 518 14 2834,2838,5450,5748,5875,5907,5973,5976,6074,6078,6089,6120,6124,6135,	
82 1 518 1 2833,	
Cmáx 4 518 4 2830,2890,3022,5945,	
chino 1 518 1 6272,	
Diltiazem 1 518 1 2992,	
redujo 4 518 4 2791,2825,6086,6132,	
tenían 2 518 2 4620,4628,	
repetidas 4 518 4 2788,2862,5431,5479,	
(inductor 1 518 1 2781,	
administrar 2 518 2 2771,6594,	
afectó 5 518 5 2762,2865,3013,3038,3085,	
sanos 7 518 7 2753,2964,5413,5762,5852,6095,6144,	
policloruro 1 518 1 6581,	
voluntarios 3 518 3 2752,5761,5851,	
Una 1 518 1 2745,	
Medicamentos 1 518 1 6940,	
afectadas 1 518 1 2744,	
administró 1 518 1 2724,	
tmax 3 518 3 2721,3099,5581,	
Cmax 8 518 8 2718,2735,2967,3098,3120,3185,3207,5573,	
Reino 1 518 1 6879,	
incrementos 1 518 1 2715,	
reflejó 1 518 1 2712,	
respectivamente 10 518 10 2704,2839,2905,2978,3035,3117,3205,3228,6079,6125,	
listados 1 518 1 4315,	
80% 1 518 1 2703,	
141% 1 518 1 2701,	
183% 1 518 1 2700,	
AUC 13 518 13 2696,2738,2827,2893,2970,3025,3102,3123,3190,3213,5947,6065,6111,	
produjeron 1 518 1 2692,	
10 6 518 6 2681,2805,2902,3001,4363,6916,	
2h 1 518 1 2674,	
normativas 1 518 1 6760,	
(300 3 518 3 2667,2678,2690,	
simultáneamente 2 518 2 2664,2754,	
administrados 3 518 3 2663,2673,7524,	
A 6 518 6 2657,4673,4692,4891,5167,6058,	
incrementados 1 518 1 2653,	
grado 4 518 4 2645,2871,3091,3178,	
tasa 11 518 11 2643,2869,3088,3175,4232,4248,4738,4795,5172,5981,6571,	
Rifampicina 1 518 1 2780,	
CYP3A4) 7 518 7 2641,2783,2857,2922,2995,3073,3160,	
(sustrato 1 518 1 2639,	
Ciclosporina 1 518 1 2638,	
4) 7 518 7 2637,2853,2918,2991,3977,5152,5351,	
testículos 2 518 2 6235,6447,	
incrementan 3 518 3 2593,2607,3753,	
motivo 2 518 2 5961,6587,	
disminuyen 2 518 2 2587,2613,	
afectan 1 518 1 2571,	
consecución 1 518 1 6161,	
sustancias 3 518 3 2569,3357,3510,	
proteína 1 518 1 4443,	
influenciadas 1 518 1 2566,	
posterior 2 518 2 2560,4083,	
delgado 1 518 1 2554,	
intestino 1 518 1 2553,	
excluir 1 518 1 3295,	
situada 1 518 1 2550,	
P 2 518 2 2548,5712,	
preparación 1 518 1 6650,	
glicoproteína 2 518 2 2547,5711,	
multifármaco 1 518 1 2546,	
flujo 2 518 2 2545,3455,	
bomba 1 518 1 2543,	
sustrato 2 518 2 2540,5703,	
isoenzima 1 518 1 2534,	
intestinal 1 518 1 2527,	
eu 1 518 1 6946,	
metabolizado 1 518 1 2523,	
sacarasa 1 518 1 9579,	
medicamentos 2 518 2 2514,9605,	
Interacción 1 518 1 2510,	
asociados 4 518 4 2502,4177,6488,9556,	
(SHU/PTT/MAT) 2 518 2 2501,9555,	
microangiopatía 2 518 2 2499,9553,	
trombótica 4 518 4 2497,2500,9551,9554,	
urémico 2 518 2 2493,9547,	
hemolítico 2 518 2 2492,9546,	
síndrome 2 518 2 2491,9545,	
Incompatibilidades 1 518 1 6530,	
2% 3 518 3 2440,4780,9494,	
final 1 518 1 5468,	
nefrótico) 3 518 3 2437,5162,9491,	
(síndrome 3 518 3 2436,5161,9490,	
nefrosis 3 518 3 2435,5160,9489,	
aparición 3 518 3 2433,5158,9487,	
notificó 3 518 3 2430,5155,9484,	
común 2 518 2 2403,9457,	
rasgo 2 518 2 2402,9456,	
observó 4 518 4 2400,3250,6412,9454,	
calcineurina 17 518 17 2389,2465,2485,2507,4170,4182,4200,4989,5144,5199,5255,5338,5370,9443,9519,9539,9561,	
conversión 10 518 10 2384,2421,2461,4196,4983,5099,5186,9438,9475,9515,	
evaluación 2 518 2 2381,9435,	
estudio 11 518 11 2379,2445,3273,4185,4954,4969,5211,6423,6466,9433,9499,	
urinarias 5 518 5 2376,2411,5273,9430,9465,	
proteínas 8 518 8 2375,2410,2574,4348,5221,5272,9429,9464,	
excreción 6 518 6 2373,2408,5219,5270,9427,9462,	
periódico 2 518 2 2370,9424,	
cuantitativo 2 518 2 2369,9423,	
control 2 518 2 2368,9422,	
realizar 2 518 2 2366,9420,	
recuperación 3 518 3 2359,4155,9413,	
dolor 1 518 1 3726,	
retrasar 3 518 3 2357,4153,9411,	
continuada 2 518 2 2335,9389,	
coadministración 2 518 2 2334,9388,	
recomendarse 3 518 3 2332,7114,9386,	
seguían 2 518 2 2327,9381,	
neoplasia 2 518 2 2320,9374,	
Poco 1 518 1 3855,	
incidencia 4 518 4 2318,3744,4896,9372,	
así 3 518 3 2312,4864,9366,	
altas 4 518 4 2307,5320,5327,9361,	
éxito 2 518 2 2294,9348,	
excluyendo 1 518 1 4731,	
retiró 3 518 3 2292,4599,9346,	
controles 2 518 2 2283,9337,	
absorbe 1 518 1 5399,	
comparación 10 518 10 2272,2322,4719,4916,5329,6029,6091,6137,9326,9376,	
calculada 7 518 7 2270,2311,4800,4965,5226,9324,9365,	
glomerular 6 518 6 2269,2310,4235,4798,9323,9364,	
filtración 6 518 6 2268,2309,4797,5983,9322,9363,	
bajas 2 518 2 2266,9320,	
tasas 8 518 8 2264,2305,5062,5257,5314,5322,9318,9359,	
altos 3 518 3 2259,5128,9313,	
TITULAR 1 518 1 6862,	
tuvieron 5 518 5 2256,2297,5313,9310,9351,	
tratados 8 518 8 2243,2276,3650,4120,5299,5333,9297,9330,	
precaución 2 518 2 2240,9294,	
tenerse 2 518 2 2239,9293,	
perjudicial 2 518 2 2233,9287,	
usarse 2 518 2 6652,6772,	
conocidos 2 518 2 2228,9282,	
coadministran 2 518 2 2225,9279,	
sérica 7 518 7 2213,2262,2303,4623,9267,9316,9357,	
creatinina 7 518 7 2212,2261,2302,4622,9266,9315,9356,	
formas 1 518 1 2517,	
Producto 2 518 2 2188,9242,	
Características 2 518 2 2186,9240,	
Resúmenes 2 518 2 2183,9237,	
respectivos 2 518 2 2182,9236,	
descritos 2 518 2 2179,9233,	
media 3 518 3 4792,5115,5457,	
anticonceptivo 3 518 3 3283,3309,3590,	
adversos 5 518 5 2178,3748,4252,4310,9232,	
efectos 9 518 9 2177,3660,3688,3747,4130,4251,4309,4417,9231,	
rabdomiólisis 2 518 2 2174,9228,	
fibrato 2 518 2 2164,9218,	
(hidroxi-metil-glutaril)- 1 518 1 2159,	
HMG 2 518 2 2158,9214,	
inhibidor 7 518 7 2155,2482,4167,5336,5368,9211,9536,	
administra 3 518 3 2153,3052,9209,	
les 3 518 3 2152,4926,9208,	
tolerada 2 518 2 2140,9196,	
fibratos 2 518 2 2136,9192,	
reductasa 4 518 4 2134,2161,9190,9216,	
(Hypericum 1 518 1 3386,	
CoA 3 518 3 2133,2160,9189,	
HMG- 2 518 2 2132,9188,	
continuar 2 518 2 2114,9170,	
reevaluarse 2 518 2 2110,9166,	
refractaria 2 518 2 2108,9164,	
riesgo/beneficio 4 518 4 2099,2112,9155,9168,	
iniciar 2 518 2 2090,9146,	
establecida 2 518 2 2087,9143,	
lípidos 2 518 2 2082,9138,	
reductores 2 518 2 2080,9136,	
(EMEA) 1 518 1 6941,	
ejercicio 2 518 2 2077,9133,	
dieta 2 518 2 2076,9132,	
adoptarse 2 518 2 2073,9129,	
detectase 2 518 2 2070,9126,	
tests 2 518 2 2064,9119,	
hiperlipidemia 8 518 8 2062,2071,2086,2107,9117,9127,9142,9163,	
monitorizados 6 518 6 2058,2167,3146,3235,9113,9221,	
reciban 2 518 2 2054,9109,	
requerir 2 518 2 2049,9104,	
colesterol 2 518 2 2043,9098,	
séricos 2 518 2 2041,9096,	
(CYP3A4) 1 518 1 5708,	
reclutamiento 2 518 2 4221,5019,	
mg) 4 518 4 2668,2679,2691,2936,	
CMV 2 518 2 2021,9076,	
enfermedad 2 518 2 2019,9074,	
especialmente 2 518 2 2012,9067,	
(CMV) 2 518 2 2004,9059,	
citomegalovirus 2 518 2 2003,9058,	
	5 1 518 1 4370,	
max 3 518 3 3136,3187,3210,	
carinii 4 518 4 1976,1990,9031,9045,	
Pneumocystis 4 518 4 1975,1989,9030,9044,	
neumonía 6 518 6 1973,1986,4029,4255,9028,9041,	
antimicrobiana 4 518 4 1967,1983,9022,9038,	
medios 3 518 3 5635,6063,6109,	
protección 2 518 2 1959,9014,	
factor 2 518 2 1957,9012,	
protectoras 2 518 2 1951,9006,	
prendas 2 518 2 1950,9005,	
fibrilación 1 518 1 4295,	
usando 2 518 2 1949,9004,	
sujetos 5 518 5 2963,4884,5412,6094,6143,	
UV 2 518 2 1948,9003,	
luz 5 518 5 1942,1947,6678,8997,9002,	
global 1 518 1 5060,	
exposición 5 518 5 1939,2876,5910,6209,8994,	
cáncer 2 518 2 1933,8988,	
4% 1 518 1 4932,	
padecer 2 518 2 1932,8987,	
(CsA) 1 518 1 2658,	
Como 2 518 2 1921,8976,	
angioneurótico 2 518 2 1920,8975,	
tipo 3 518 3 1917,6713,8972,	
radiomarcado 1 518 1 3598,	
desencadenado 2 518 2 1914,8969,	
angiotensina) 2 518 2 1912,8967,	
convertidora 2 518 2 1910,8965,	
enzima 2 518 2 1909,8964,	
(inhibidores 2 518 2 1906,8961,	
IECA 2 518 2 1905,8960,	
raras 2 518 2 1897,8952,	
vasculitis 2 518 2 1889,8944,	
dermatitis 2 518 2 1886,8941,	
angioedema 2 518 2 1885,8940,	
anafilácticas/anafilactoides 2 518 2 1884,8939,	
incluían 1 518 1 4046,	
hipersensibilidad 4 518 4 1881,1891,8936,8946,	
leve 1 518 1 6052,	
reacciones 14 518 14 1879,1883,1915,3626,3702,3766,3794,3813,4526,5079,6195,8934,8938,8970,	
asociado 4 518 4 1873,2034,8928,9089,	
inmunosupresor 4 518 4 1862,2093,8917,9149,	
fructosa 1 518 1 9586,	
resultando 2 518 2 1847,8902,	
bronquial 2 518 2 1846,8901,	
vieron 2 518 2 2651,2743,	
anastomosis 2 518 2 1845,8900,	
significativos 2 518 2 1827,8882,	
celular 1 518 1 4474,	
hemodinámicamente 2 518 2 1826,8881,	
túbulos) 1 518 1 6460,	
derrames 2 518 2 1825,8880,	
(incluyendo 4 518 4 1824,4021,4729,8879,	
pleural 2 518 2 1820,8875,	
	Prospectos 1 518 1 9603,	
derrame 4 518 4 1819,1822,8874,8877,	
linfedema 2 518 2 1818,8873,	
periférico 3 518 3 1817,3730,8872,	
acumulación 2 518 2 1812,8867,	
También 5 518 5 1806,2428,5153,8861,9482,	
anómala 2 518 2 1803,8858,	
post-aleatorización 1 518 1 4771,	
placebo 2 518 2 2280,9334,	
presentarmayor 1 518 1 1800,	
kg/m2 2 518 2 1798,8851,	
pericárdico 2 518 2 1823,8878,	
30 5 518 5 1797,5972,6624,6723,8850,	
superior 2 518 2 1795,8848,	
IMC 2 518 2 1794,8847,	
médica 2 518 2 1789,8842,	
hernia 1 518 1 4092,	
bibliografía 2 518 2 1788,8841,	
Basándose 3 518 3 1782,4333,8835,	
dehiscencia 6 518 6 1779,1842,4090,4095,8832,8897,	
linfocele 3 518 3 1777,3728,8830,	
heridas 7 518 7 1770,1781,1805,4100,8823,8834,8860,	
cicatrización 5 518 5 1768,1802,4081,8821,8857,	
casos 17 518 17 1761,1810,1840,1971,3658,3981,3999,4013,4050,4079,4128,4324,6350,8814,8865,8895,9026,	
notificado 12 518 12 1760,1809,1839,1970,2925,3980,3998,4078,8813,8864,8894,9025,	
muerte 6 518 6 1757,4262,5070,5265,5324,8810,	
injerto 12 518 12 1754,2354,4150,4260,4648,4683,4705,4858,5068,5263,8807,9408,	
Anticonceptivos 1 518 1 3246,	
pérdida 7 518 7 1752,4258,4646,4733,5066,5261,8805,	
desembocando 2 518 2 1747,8800,	
(HAT) 2 518 2 1746,8799,	
33 1 518 1 6088,	
controlar 2 518 2 2169,9223,	
arteria 2 518 2 1744,8797,	
trombosis 2 518 2 1741,8794,	
incremento 7 518 7 1739,2037,2405,2694,8792,9092,9459,	
tacrolimus 3 518 3 1734,4428,8787,	
están 3 518 3 1713,4418,8766,	
pulmón 4 518 4 1705,1870,8758,8925,	
hígado 5 518 5 1703,1726,2531,8756,8779,	
inmunosupresora 3 518 3 1696,5752,8749,	
establecido 4 518 4 1687,2454,8740,9508,	
sepsis 2 518 2 1683,8736,	
	6 1 518 1 6500,	
mortales 5 518 5 1680,1851,4039,8733,8906,	
oportunistas 2 518 2 1677,8730,	
infección 2 518 2 1673,8726,	
aumentar 5 518 5 1668,3334,3369,3462,8721,	
inmune 3 518 3 1665,4531,8718,	
sistema 5 518 5 1664,3900,3906,4530,8717,	
excesiva 2 518 2 1662,8715,	
significativamente 13 518 13 2652,2866,3014,3086,3173,4739,4811,4869,4902,4951,5126,5179,5318,	
supresión 2 518 2 1661,8714,	
triglicéridos 2 518 2 2046,9101,	
8) 6 518 6 1659,1895,5042,5166,8712,8950,	
inmunosupresión 8 518 8 1655,2222,3841,3958,4508,6370,8708,9276,	
piel 8 518 8 1648,1935,3881,3929,3973,4941,8701,8990,	
particularmente 2 518 2 1645,8698,	
tumores 4 518 4 1644,3968,6335,8697,	
desarrollo 5 518 5 1638,2172,3963,8691,9226,	
infecciones 7 518 7 1634,1676,1679,3719,8687,8729,8732,	
susceptibilidad 5 518 5 1632,1670,3961,8685,8723,	
diálisis 2 518 2 4618,5969,	
rifabutina) 3 518 3 1625,2606,8678,	
rifampicina 6 518 6 1624,2604,2790,2814,2849,8677,	
claritromicina) 3 518 3 1619,2586,8672,	
itraconazol 3 518 3 1616,2583,8669,	
ketoconazol 5 518 5 1614,2581,2864,2914,8667,	
FARMACOLÓGICAS 1 518 1 4366,	
(tales 6 518 6 1612,1622,2579,2602,8665,8675,	
trombocitopénica 2 518 2 2496,9550,	
potentes 3 518 3 1609,2627,8662,	
co-administración 6 518 6 1604,2622,2910,2928,2983,8657,	
macho) 1 518 1 6323,	
estables 3 518 3 1592,5427,8645,	
alcancen 2 518 2 1590,8643,	
prolongado 2 518 2 1584,8637,	
hipocalemia 1 518 1 3717,	
periodo 3 518 3 1583,5622,8636,	
volumen 1 518 1 6842,	
prolonga 2 518 2 1562,8615,	
Dado 3 518 3 1556,3619,8609,	
reducción 10 518 10 1532,1545,2315,4058,5872,5978,6480,8584,8597,9369,	
SL6 1 518 1 6877,	
atenuadas 2 518 2 1500,8551,	
vacunas 2 518 2 1499,8550,	
evitar 2 518 2 1495,8546,	
efectiva 3 518 3 1492,5490,8543,	
incluyendo 13 518 13 1485,1674,1776,1882,2094,4089,4254,5729,8536,8727,8829,8937,9150,	
Durante 7 518 7 1480,2141,2192,3570,8531,9197,9246,	
vacunación 4 518 4 1479,1488,8530,8539,	
respuesta 3 518 3 1476,6384,8527,	
variar 2 518 2 1474,8525,	
novo 8 518 8 1466,1722,1868,5298,5366,8516,8775,8923,	
marco 2 518 2 1461,8511,	
Ac) 2 518 2 1455,8505,	
CYP2D6 1 518 1 3404,	
(IL-2R 2 518 2 1454,8504,	
bajos 2 518 2 2300,9354,	
IL-2 4 518 4 1453,5312,5347,8503,	
receptor 4 518 4 1451,5310,5345,8501,	
frente 2 518 2 1449,8499,	
posteriores 4 518 4 1434,2418,8484,9472,	
obtenida 2 518 2 1430,8480,	
extensamente 3 518 3 1418,2522,8468,	
Sirolimus 11 518 11 1413,2520,2536,3036,4075,4383,5701,5713,5734,6247,8463,	
citotóxicos 2 518 2 1412,8462,	
anticuerpos 4 518 4 1411,1448,8461,8498,	
mofetil 6 518 6 1408,1440,5012,5303,8458,8490,	
micofenolato 6 518 6 1407,1439,5011,5302,8457,8489,	
azatioprina 5 518 5 1406,2285,5013,8456,9339,	
púrpura 2 518 2 2495,9549,	
administrado 2 518 2 1399,8449,	
inmunosupresores 13 518 13 1392,1424,1472,1484,3849,4377,4432,5009,6344,8442,8474,8523,8535,	
agentes 19 518 19 1391,1404,1423,2079,2191,2227,3350,3488,3848,4376,4431,5008,6343,8441,8454,8473,9135,9245,9281,	
concomitante 12 518 12 1388,1901,2125,2195,2477,4162,5006,8438,8956,9181,9249,9531,	
estratificado 1 518 1 4959,	
alto 5 518 5 1379,2016,5856,8429,9071,	
adecuadamente 2 518 2 1374,8424,	
estudiado 4 518 4 1373,1417,8423,8467,	
(24 1 518 1 6700,	
especiales 5 518 5 1366,6555,6657,6730,8416,	
precauciones 2 518 2 1365,8415,	
Advertencias 2 518 2 1363,8413,	
activo 3 518 3 1354,3415,8404,	
principio 3 518 3 1353,3414,8403,	
Hipersensibilidad 2 518 2 1351,8401,	
material 1 518 1 6805,	
Contraindicaciones 2 518 2 1350,8400,	
5) 4 518 4 1347,1629,8397,8682,	
interaccionar 2 518 2 1341,8391,	
exfoliativa 2 518 2 1887,8942,	
productos 2 518 2 1335,8385,	
(microemulsión) 4 518 4 1332,2768,2779,8382,	
consideraciones 2 518 2 1327,8377,	
Otras 3 518 3 1326,3319,8376,	
acuerdo 4 518 4 1312,3780,6757,8362,	
realizarse 2 518 2 1310,8360,	
equivalentes 3 518 3 1302,5940,8352,	
elevado 3 518 3 1960,4644,9015,	
convertidas 2 518 2 1300,8350,	
desconocida 1 518 1 4020,	
sido 5 518 5 1299,3662,4132,6347,8349,	
utilizando 4 518 4 1294,2063,8344,9118,	
medidas 5 518 5 1293,2074,4329,8343,9130,	
ficha 2 518 2 1290,8340,	
indican 2 518 2 1287,8337,	
Todas 2 518 2 1280,8330,	
medicinales 4 518 4 1336,1339,8386,8389,	
relaciona 2 518 2 1271,8321,	
fabricante 2 518 2 1269,8319,	
referencia 4 518 4 1264,1279,8314,8329,	
registrado 2 518 2 1259,8309,	
inmunoensayo 2 518 2 1258,8308,	
método 5 518 5 1256,1276,3589,8306,8326,	
solar 4 518 4 1943,1955,8998,9010,	
use 2 518 2 1254,8304,	
Cuando 5 518 5 1252,2223,2722,8302,9277,	
intercambiables 2 518 2 1251,8301,	
técnicas 2 518 2 1248,8298,	
mediante 3 518 3 1246,4398,8296,	
animales 3 518 3 3540,4510,6205,	
obtenidos 5 518 5 1245,5537,5836,6141,8295,	
inmunoensayos 2 518 2 1240,8290,	
Agencia 1 518 1 6937,	
mide 2 518 2 1233,8283,	
clínica 3 518 3 1225,6402,8275,	
práctica 2 518 2 1224,8274,	
medir 2 518 2 1214,8264,	
utilizado 5 518 5 1208,1855,6741,8258,8910,	
dosificaciones 1 518 1 7913,	
sugiere 2 518 2 3285,4436,	
han 27 518 27 1207,1298,1759,1808,1838,1872,1969,2453,3497,3541,3639,3661,3683,3979,3997,4077,4109,4131,6346,8257,8348,8812,8863,8893,8927,9024,9507,	
cromatográficos 8 518 8 1205,1237,1296,1303,8255,8287,8346,8353,	
Hubo 3 518 3 4246,4736,6034,	
métodos 8 518 8 1204,1210,1236,1295,8254,8260,8286,8345,	
basan 2 518 2 1202,8252,	
24 8 518 8 1197,2416,4676,4804,5147,6630,8247,9470,	
recomendados 4 518 4 1191,1714,8241,8767,	
intervalos 3 518 3 1190,5988,8240,	
semivida 6 518 6 1188,1564,5467,5489,8238,8617,	
prolongación 3 518 3 1185,6147,8235,	
produce 3 518 3 1182,6156,8232,	
estacionario 3 518 3 1179,6164,8229,	
Período 1 518 1 6617,	
alimentos 1 518 1 5921,	
alcanzar 3 518 3 1176,5896,8226,	
retraso 8 518 8 1174,1765,2349,4145,6158,8224,8818,9403,	
estable 4 518 4 1171,5475,5501,8221,	
muestren 2 518 2 1168,8218,	
7 8 518 8 1160,2974,3226,3671,5508,5649,6861,8210,	
medirse 2 518 2 1152,8202,	
la(s) 2 518 2 1130,8180,	
Las 8 518 8 1114,3701,3793,5061,5078,5256,6194,8164,	
24% 1 518 1 3139,	
deberá 1 518 1 1109,	
adición 2 518 2 1099,8148,	
debido 5 518 5 1096,1172,5030,8145,8222,	
mL/min 5 518 5 4971,5029,5052,5113,5216,	
excede 2 518 2 1092,8141,	
estimada 2 518 2 1091,8140,	
40 6 518 6 1085,1094,4240,5587,8134,8143,	
exceder 2 518 2 1083,8132,	
(PVC) 1 518 1 6584,	
diaria 4 518 4 1080,1090,8129,8139,	
máxima 2 518 2 1077,8126,	
mantenimiento- 2 518 2 1070,8119,	
(nueva 2 518 2 1067,8116,	
03 1 518 1 3264,	
3x 2 518 2 1066,8115,	
retirada 2 518 2 4636,4928,	
Dosis 2 518 2 1060,8109,	
considerablemente 2 518 2 1054,8103,	
incrementar 5 518 5 1053,2487,4172,8102,9541,	
carga 14 518 14 1049,1062,1104,1108,1133,1150,1569,8098,8111,8153,8157,8183,8200,8622,	
(287 1 518 1 6032,	
considerarse 8 518 8 1045,2097,2215,3149,3238,8094,9153,9269,	
Además 3 518 3 1037,4577,8086,	
actual) 4 518 4 1036,1074,8085,8123,	
disminuyó 1 518 1 3137,	
deseada/concentración 2 518 2 1034,8084,	
(concentración 2 518 2 1033,8083,	
actual 4 518 4 1031,1226,8081,8276,	
nueva 7 518 7 1025,1040,2432,5157,8075,8089,9486,	
proporción 2 518 2 1023,8073,	
simple 2 518 2 1022,8072,	
ciclosporina) 2 518 2 1009,8059,	
(tras 2 518 2 1004,8054,	
(gp-P) 1 518 1 2549,	
adicionales 2 518 2 1000,8050,	
requieren 2 518 2 998,8048,	
mediados 1 518 1 4419,	
Si 6 518 6 991,1087,3050,6679,8041,8136,	
eliminación 13 518 13 987,2561,4558,4659,4715,4755,4822,4876,6557,6732,6737,6767,8037,	
corresponder 2 518 2 982,8032,	
aumenta 6 518 6 976,3959,4069,5462,6569,8026,	
velocidad 4 518 4 971,985,8021,8035,	
consecuencia 1 518 1 5083,	
inmunosupresiva 2 518 2 961,8011,	
aumento 6 518 6 957,3735,5887,5904,6309,8007,	
limitarse 2 518 2 1937,8992,	
veces) 4 518 4 954,969,8004,8019,	
(incremento 4 518 4 951,966,8001,8016,	
interacción 5 518 5 949,2519,3252,3275,7999,	
ausencia 4 518 4 947,963,7997,8013,	
mayor 10 518 10 941,1631,1929,4249,5766,6012,7991,8684,8854,8984,	
veces 12 518 12 940,2823,2904,2977,3034,3116,3132,3204,3227,5465,5891,7990,	
necesitará 2 518 2 937,7987,	
recibían 3 518 3 1774,5545,8827,	
medio 3 518 3 932,6004,7982,	
término 2 518 2 931,7981,	
Por 6 518 6 930,1977,2555,6585,7980,9032,	
incremente 2 518 2 925,7975,	
multicéntrico 1 518 1 4956,	
interrumpa 2 518 2 920,7970,	
zumo 8 518 8 3468,5930,5949,6537,6550,6814,6827,6851,	
descenderán 2 518 2 915,7965,	
consiguiente 2 518 2 910,7960,	
metabolismo 9 518 9 905,2589,2609,3332,3371,3473,3910,5954,7954,	
inhibe 5 518 5 903,3394,4384,4453,7952,	
Tras 3 518 3 879,5451,7928,	
anterior 2 518 2 878,7869,	
cambio 5 518 5 875,1572,7866,7906,8625,	
hepatocelular 1 518 1 6319,	
aumentos 1 518 1 2885,	
días 10 518 10 870,1113,1127,1161,5509,6625,7861,8163,8177,8211,	
obtenido 2 518 2 866,7857,	
nivel 4 518 4 864,3992,4072,7855,	
único 2 518 2 863,7854,	
basarse 4 518 4 858,1019,7849,8069,	
deben 23 518 23 857,1120,1151,1309,1575,2056,2072,2165,3054,3144,3148,3233,3237,4327,6821,7848,8170,8201,8359,8628,9111,9128,9219,	
ajustes 8 518 8 851,999,1017,1305,7842,8049,8067,8355,	
manera 4 518 4 848,2103,7839,9159,	
jeringas 2 518 2 6628,6724,	
De 4 518 4 847,2100,7838,9156,	
leche 2 518 2 3607,3617,	
alimento 2 518 2 842,7833,	
consecuentemente 2 518 2 838,7829,	
nutrición 1 518 1 3914,	
relación 4 518 4 824,3824,5511,7815,	
tomarse 2 518 2 819,7810,	
consecutivos 2 518 2 1167,8217,	
variabilidad 3 518 3 816,6037,7807,	
minimizar 2 518 2 814,7805,	
laboratorio 4 518 4 812,2066,7803,9121,	
parámetros 7 518 7 810,3644,4114,5533,5619,6166,7801,	
CL/F/W 1 518 1 5595,	
solubilidad 1 518 1 4337,	
tisulares 2 518 2 808,7799,	
biopsias 2 518 2 807,7798,	
(FG) 1 518 1 4799,	
aumentó 2 518 2 2815,3172,	
signos/síntomas 2 518 2 805,7796,	
prestar 2 518 2 799,7790,	
ajustar 2 518 2 792,7783,	
base 8 518 8 790,1426,3216,4837,4961,7781,7889,8476,	
única 7 518 7 789,2747,2803,2932,3278,5757,7780,	
especial 4 518 4 779,801,7770,7792,	
necesidad 4 518 4 775,960,7766,8010,	
telitromicina 3 518 3 1617,2584,8670,	
tengan 2 518 2 774,7765,	
mTOR 1 518 1 4478,	
probable 2 518 2 770,7761,	
elimina 2 518 2 765,7756,	
notablemente 2 518 2 762,7753,	
carbamazepina 1 518 1 3389,	
reduce 2 518 2 761,7752,	
) 9 518 9 1386,2450,5885,5901,6614,8436,8521,8608,9504,	
(3) 2 518 2 754,7745,	
C) 3 518 3 6106,6640,6668,	
y/o 9 518 9 753,2135,2163,5719,6448,6608,7744,9191,9217,	
5); 2 518 2 752,7743,	
interrupción 7 518 7 748,881,1006,3583,7739,7930,8056,	
conjuntamente 4 518 4 743,1400,7734,8450,	
administran 2 518 2 742,7733,	
CYP3A4 13 518 13 740,1611,2535,2578,2601,2629,2633,3328,3367,3476,5957,7731,8664,	
inhibidores 23 518 23 738,1608,2129,2387,2463,2504,2576,2626,3323,3361,3449,4179,4198,4987,5142,5196,5252,7729,8661,9185,9441,9517,9558,	
inductores 7 518 7 736,1621,2599,2631,3365,7727,8674,	
(2) 2 518 2 734,7725,	
historial 1 518 1 9575,	
hepática; 2 518 2 733,7724,	
presentaninsuficiencia 1 518 1 732,	
(1) 2 518 2 728,7718,	
poblaciones 5 518 5 727,773,6174,7717,7764,	
siguientes 12 518 12 726,1403,1995,2009,3509,3580,4848,6224,7716,8453,9050,9064,	
extracción 1 518 1 6573,	
estrechamente 2 518 2 716,7706,	
Deben 2 518 2 714,7704,	
monitorización 4 518 4 703,781,7693,7772,	
óptima 4 518 4 700,849,7690,7840,	
cromatográfico) 4 518 4 697,900,7687,7949,	
ensayo 15 518 15 696,1212,1315,4554,5567,5608,5643,5661,5685,6262,6275,6289,7686,8262,8365,	
valores 13 518 13 694,1242,1273,2888,3020,5659,5683,6062,6108,6140,7684,8292,8323,	
(expresado 2 518 2 692,7682,	
objetivo 7 518 7 686,891,1308,7676,7926,7940,8358,	
aparentemente 2 518 2 2138,9194,	
concentraciones 16 518 16 676,1056,1115,1282,1322,1591,2793,3425,5496,5818,7666,8105,8165,8332,8372,8644,	
horas 15 518 15 670,829,1198,2686,2726,2758,2774,2950,2958,5421,5549,6631,7660,7820,8248,	
recibieron 10 518 10 664,1835,1965,4567,4818,5415,5429,7654,8890,9020,	
mayoría 10 518 10 659,1012,1749,3655,3832,4125,4394,7649,8062,8802,	
danazol 1 518 1 3360,	
fármaco 7 518 7 657,709,784,3280,7647,7699,7775,	
modificar 2 518 2 647,7637,	
necesario 7 518 7 646,1052,3065,3569,6681,7636,8101,	
cuidadosamente 4 518 4 630,1514,7621,8566,	
controlado 1 518 1 4958,	
monitorizar 6 518 6 629,1121,1513,7620,8171,8565,	
aproximadamente 7 518 7 621,2698,2820,2831,5447,5463,7612,	
mitad 4 518 4 620,1540,7611,8592,	
reducir 4 518 4 611,3330,3373,7602,	
primera 1 518 1 6899,	
grave 7 518 7 608,1139,1528,6102,7599,8189,8580,	
función 20 518 20 597,1542,2203,2236,2352,2362,3769,4148,4158,4630,4862,5054,5353,6176,7588,8594,9257,9290,9406,9416,	
alteración 4 518 4 594,1763,7585,8816,	
pared 1 518 1 2526,	
reducido 2 518 2 590,7581,	
diferencia 5 518 5 2760,4698,4784,4853,5613,	
aclaramiento 5 518 5 585,1547,2817,7576,8599,	
hepática 21 518 21 583,598,607,626,1138,1510,1527,1745,4003,6051,6101,6155,6243,7574,7589,7598,7617,8188,8562,8579,8798,	
ajuste 7 518 7 570,1142,2217,3067,7561,8192,9271,	
ningún 3 518 3 569,6803,7560,	
(fosfatidilcolina 1 518 1 6510,	
requiere 4 518 4 568,701,7559,7691,	
insuficiencia 18 518 18 564,582,606,625,1137,1509,1526,6050,6100,6154,7555,7573,7597,7616,7723,8187,8561,8578,	
822) 3 518 3 559,5842,7519,	
= 9 518 9 558,1029,1065,4228,4271,5841,7518,8079,8114,	
(n 5 518 5 557,4227,4270,5840,7517,	
adulta 3 518 3 550,5839,7510,	
producida 2 518 2 1987,9042,	
población 3 518 3 549,5838,7509,	
similares 8 518 8 544,5072,5267,5833,6171,6210,7504,7537,	
hipofosfatemia 1 518 1 3718,	
35 4 518 4 534,5823,5906,7494,	
jóvenes 3 518 3 526,5814,7486,	
rápidamente 1 518 1 5400,	
diferente 4 518 4 522,4423,5809,7482,	
responder 4 518 4 519,943,7479,7993,	
clotrimazol 1 518 1 3352,	
podrían 2 518 2 518,7478,	
determinar 5 518 5 515,1320,5805,7475,8370,	
años 17 518 17 513,542,556,5077,5170,5235,5803,5828,5847,5995,6001,6621,7473,7502,7516,7534,7550,	
hidroxidesmetil 1 518 1 5733,	
65 11 518 11 512,541,555,5802,5827,5846,7472,7501,7515,7533,7549,	
> 6 518 6 510,539,5800,5825,7470,7499,	
canales 1 518 1 3346,	
número 4 518 4 506,4653,5796,7466,	
incluyeron 4 518 4 504,4579,5794,7464,	
clínicos 18 518 18 500,806,1395,1433,1718,2122,3785,4539,5290,5790,6201,6213,7458,7797,8445,8483,8771,9178,	
ensayos 15 518 15 499,1394,1432,1717,2121,3784,4657,5789,6200,6252,7457,8444,8482,8770,9177,	
Los 37 518 37 498,527,1189,1241,1304,1471,2051,2241,2286,2575,2598,3019,3140,3229,3322,3364,3448,3537,4639,5532,5632,5788,5815,6165,6363,7456,7487,7520,7870,8239,8291,8354,8522,9106,9295,9340,9562,	
(>65 2 518 2 496,7454,	
avanzada 2 518 2 495,7453,	
edad 6 518 6 494,5849,5990,6018,6046,7452,	
2) 13 518 13 489,577,602,846,1555,1599,5699,7447,7568,7593,7837,8607,8652,	
apartado 41 518 41 487,575,600,750,844,1345,1383,1468,1627,1657,1893,2425,2447,2635,2851,2916,2989,3546,3975,4138,4243,5040,5150,5164,5349,5697,6611,6646,7445,7566,7591,7741,7835,8395,8433,8518,8680,8710,8948,9479,9501,	
limitada 4 518 4 483,4286,6403,7441,	
disponible 3 518 3 481,6930,7439,	
farmacocinética 8 518 8 480,950,2764,3040,3253,3302,7438,8000,	
recomendar 2 518 2 469,7427,	
experiencia 4 518 4 467,3790,4285,7425,	
suficiente 6 518 6 466,507,4654,5797,7424,7467,	
hay 4 518 4 465,3288,4283,7423,	
No 25 518 25 464,566,644,1600,1684,2330,2451,2618,2840,2906,2979,3248,3495,3525,3608,3681,5610,7094,7422,7557,7634,8653,8737,9384,9505,	
años) 4 518 4 463,497,7421,7455,	
riesgode 1 518 1 1801,	
18 8 518 8 462,553,5844,6000,7420,7513,7547,8557,	
(< 2 518 2 461,7419,	
adolescentes 4 518 4 460,477,7418,7435,	
bloqueo 2 518 2 4400,4482,	
niños 8 518 8 458,475,485,1829,7416,7433,7443,8884,	
específicas 3 518 3 444,4486,7402,	
recomendaciones 2 518 2 443,7401,	
trombocitopenia 1 518 1 3715,	
permitir 2 518 2 442,7400,	
limitados 2 518 2 440,7398,	
seguridad 10 518 10 437,1689,2456,4191,4978,5038,6193,7395,8742,9510,	
datos 9 518 9 433,528,1785,3527,4842,5816,7391,7488,8838,	
Actualmente 3 518 3 431,4282,7389,	
observa 2 518 2 421,7379,	
eficacia 11 518 11 418,435,1691,2458,3307,4193,4980,7376,7393,8744,9512,	
elevados 5 518 5 411,2210,4010,7369,9264,	
fluconazol; 1 518 1 3353,	
requieran 2 518 2 404,7363,	
(predominantemente 2 518 2 402,7361,	
transplante 23 518 23 397,537,1463,1701,1724,1866,2011,2030,2397,4088,4216,5473,5830,7324,7356,7497,7529,8513,8754,8777,8921,9066,9085,	
indique 2 518 2 392,7351,	
escasa 2 518 2 389,7348,	
Hay 2 518 2 388,7347,	
usos 2 518 2 1711,8764,	
negra 8 518 8 387,401,430,455,7346,7360,7388,7413,	
raza 8 518 8 386,400,429,454,7345,7359,7387,7412,	
receptores 9 518 9 384,395,452,1720,4580,7343,7354,7410,8773,	
alternativo 2 518 2 381,7340,	
inmunosupresivo 2 518 2 380,7339,	
justificar 1 518 1 4634,	
e 8 518 8 376,1904,2592,3876,4408,5732,7335,8959,	
clínicamente 4 518 4 372,3254,3501,7331,	
apropiado 4 518 4 371,2218,7330,9272,	
resulte 2 518 2 370,7329,	
mayoritario 1 518 1 5738,	
intentarse 2 518 2 348,7307,	
resultado 6 518 6 344,1652,4492,4506,7303,8705,	
da 3 518 3 343,4504,7302,	
abandono 2 518 2 337,7296,	
En 63 518 63 330,366,603,622,1134,1222,1393,1425,1506,1523,1715,1896,1961,2083,2119,2205,2345,2377,3653,3759,4048,4123,4141,4183,4306,4321,4509,4836,5043,5104,5205,5287,5371,5721,5850,5964,6047,6097,6355,6372,6404,6421,6469,6626,7289,7325,7594,7613,8184,8272,8443,8475,8558,8575,8768,8951,9016,9139,9175,9259,9399,9431,9570,	
administrarse 5 518 5 327,1110,1980,7286,9035,	
ajustarse 2 518 2 305,7264,	
semanas 5 518 5 298,3579,6428,7257,7903,	
8 9 518 9 297,2449,2960,3698,3878,4320,6881,7256,9503,	
equivalente) 2 518 2 282,7241,	
vs 3 518 3 4778,4933,4972,	
técnica 4 518 4 281,1291,7240,8341,	
delfármaco) 1 518 1 7633,	
o 61 518 61 280,340,345,737,763,840,871,1125,1145,1297,1337,1355,1570,1618,1620,1704,1733,1755,1764,2078,2281,2585,2605,2630,2755,3043,4062,4575,4626,5919,6059,6286,6540,6549,6797,6813,6850,7107,7239,7299,7304,7728,7754,7831,7862,7910,8175,8195,8347,8387,8405,8623,8671,8673,8757,8786,8808,8817,9134,9335,9600,	
naranja 4 518 4 5932,6552,6816,6853,	
anastomótica 1 518 1 4096,	
monoclonal 2 518 2 279,7238,	
150-400 2 518 2 276,7235,	
son 11 518 11 274,427,438,1250,3433,3713,4313,7233,7385,7396,8300,	
primeros 3 518 3 269,5094,7228,	
2- 2 518 2 267,7226,	
concentración 22 518 22 261,530,706,1170,1194,1216,1228,1244,5406,5456,5878,5898,7220,7490,7696,7898,7920,8220,8244,8266,8278,8294,	
edema 5 518 5 1816,1919,3729,8871,8974,	
sugerido 2 518 2 259,7218,	
intervalo 10 518 10 258,685,890,1307,3806,7217,7675,7925,7939,8357,	
esteroides 2 518 2 253,7212,	
disminución 3 518 3 251,6414,7210,	
régimen 9 518 9 249,379,1861,2220,4670,7208,7338,8916,9274,	
fármaco) 5 518 5 240,324,643,7199,7283,	
cambios 2 518 2 3299,6364,	
terapéutica 12 518 12 238,322,641,655,707,782,7197,7281,7632,7645,7697,7773,	
Monitorización 8 518 8 237,321,640,654,7196,7280,7631,7644,	
cromatográfico 6 518 6 235,319,1277,7194,7278,8327,	
(ensayo 8 518 8 234,278,318,899,7193,7237,7277,7948,	
ng/ml 14 518 14 233,277,317,691,898,5580,5651,5675,5680,7192,7236,7276,7681,7947,	
12 21 518 21 232,314,690,895,1993,2949,2957,3578,4206,4675,4774,4803,5575,5700,5998,7191,7273,7526,7680,7944,9048,	
total 23 518 23 228,312,638,682,723,1219,1231,1522,2798,3107,3195,5640,5723,5741,5911,7187,7271,7629,7672,7713,8269,8281,8574,	
sangre 31 518 31 227,311,637,681,722,1218,1230,1521,2797,3061,3106,3194,3338,3377,3742,3897,5459,5513,5531,5639,5722,5740,5883,7186,7270,7628,7671,7712,8268,8280,8573,	
valle 36 518 36 225,262,309,408,633,677,865,893,1057,1116,1166,1195,1323,1517,3756,3993,4007,4073,5634,5819,7184,7221,7268,7367,7624,7667,7856,7899,7921,7942,8106,8166,8216,8245,8373,8569,	
niveles 41 518 41 224,308,407,632,718,912,1154,1165,1516,1578,2040,2209,2257,2298,2595,2615,3057,3141,3230,3336,3375,3464,3755,4006,5633,6207,6391,7183,7267,7366,7623,7708,7962,8204,8215,8568,8631,9095,9263,9311,9352,	
obtener 4 518 4 223,307,7182,7266,	
monitorizarse 7 518 7 715,1576,2201,3055,7705,8629,9255,	
individualizarse 2 518 2 220,7179,	
día 5 518 5 214,2953,5671,5695,7173,	
vez 4 518 4 212,6836,6860,7171,	
seguida 2 518 2 207,7166,	
después 26 518 26 204,271,363,671,745,830,867,1128,2675,2687,2775,2799,4297,5096,5504,5555,5629,7163,7230,7322,7661,7736,7821,7858,7904,8178,	
inhibición 3 518 3 3432,4476,4496,	
posible 7 518 7 203,1637,2171,6216,7162,8690,9225,	
sea 6 518 6 202,1051,3567,6547,7161,8100,	
pronto 2 518 2 200,7159,	
administrada 4 518 4 198,2750,7157,8160,	
inducción 6 518 6 193,651,1446,7152,7641,8496,	
dosis 79 518 79 191,216,301,405,573,613,649,757,834,927,934,978,1003,1026,1030,1041,1047,1068,1071,1076,1089,1102,1106,1131,1144,1148,1535,1567,1574,2746,2787,2802,2861,2933,2942,3069,3078,3153,3165,3241,3277,3444,4061,5416,5430,5477,5557,5666,5690,5756,7150,7175,7260,7364,7564,7604,7639,7748,7825,7977,7984,8028,8053,8076,8080,8090,8096,8117,8120,8125,8138,8151,8155,8181,8194,8198,8587,8620,8627,	
infecciosa 1 518 1 4019,	
usual 4 518 4 186,1923,7145,8978,	
dosificación 9 518 9 185,778,854,877,5381,7144,7769,7845,7868,	
pauta 3 518 3 183,5379,7142,	
La 55 518 55 182,215,241,286,478,658,698,780,901,970,1024,1075,1330,1630,1660,2642,2784,2813,2858,2996,3074,3097,3161,3184,3206,3743,3831,3957,4433,4475,4595,4791,5352,5432,5466,5510,6146,6736,6768,6923,7141,7174,7200,7245,7436,7648,7688,7771,7950,8020,8074,8124,8380,8683,8713,	
post-transplante) 2 518 2 181,7140,	
(2 3 518 3 177,5783,7136,	
asoció 2 518 2 1736,8789,	
inicial 2 518 2 176,7135,	
Terapia 4 518 4 175,283,7134,7242,	
Uso 14 518 14 172,382,456,490,560,578,1387,7131,7341,7414,7448,7551,7569,8437,	
trasplantes 2 518 2 171,7130,	
cualificado 2 518 2 169,7128,	
apropiadamente 2 518 2 168,7127,	
especialista 2 518 2 167,7126,	
dirección 2 518 2 164,7123,	
iniciarse 5 518 5 159,377,4328,7118,7336,	
debe 54 518 54 158,219,245,288,304,326,356,373,786,798,818,981,1044,1082,1262,1494,1936,1979,2096,2109,2200,2214,2238,3480,3558,3586,3632,5962,6533,6651,6771,7117,7178,7204,7247,7263,7285,7315,7332,7777,7789,7809,8031,8093,8131,8312,8545,8991,9034,9152,9165,9254,9268,9292,	
tratamiento 25 518 25 157,1482,1503,2050,2092,2116,3313,3572,3637,3828,4267,4672,4724,4831,4985,5085,5101,5281,5362,7116,8533,8554,9105,9148,9172,	
El 18 518 18 156,257,584,2022,2475,2705,3467,4067,4160,4491,5004,5927,5948,7115,7216,7575,9077,9529,	
exclusivamente 2 518 2 152,7090,	
efecto 4 518 4 2232,2706,4514,9286,	
x 2 518 2 1032,8082,	
administración 24 518 24 149,1876,1900,2124,2194,2730,2785,2845,2859,2939,2997,3075,3162,3595,3954,5392,5440,5453,6609,7087,8931,8955,9180,9248,	
forma 6 518 6 147,521,5059,5810,7085,7481,	
adultos) 2 518 2 1831,8886,	
Posología 2 518 2 145,7083,	
1) 6 518 6 142,1470,2427,4245,7080,9481,	
5 43 518 43 141,488,576,601,845,869,1158,1384,1469,1554,1598,2162,2426,2509,2659,2669,2821,2822,3131,3547,3668,4139,4244,4364,5385,5506,5692,5890,5992,6188,6703,7079,7446,7567,7592,7836,7860,8208,8434,8519,8606,8651,9480,	
desmetil 1 518 1 5731,	
secciones 6 518 6 137,1550,1594,7075,8602,8647,	
(ver 49 518 49 136,486,574,599,639,749,843,1344,1382,1467,1548,1593,1626,1656,1892,2424,2446,2634,2850,2915,2988,3545,3974,4137,4242,5039,5149,5163,5348,5696,6610,6645,7073,7444,7565,7590,7630,7740,7834,8394,8432,8517,8600,8646,8679,8709,8947,9478,9500,	
62 1 518 1 5482,	
20 5 518 5 316,897,4208,7275,7946,	
progresivamente 4 518 4 135,290,7072,7249,	
sólo 2 518 2 128,7065,	
mantenimiento 23 518 23 125,285,615,996,1043,1073,1537,2344,2395,2471,4212,4764,4995,7062,7244,7606,8046,8092,8122,8589,9398,9449,9525,	
biodisponibilidad 3 518 3 3016,5864,7099,	
terapia 18 518 18 123,242,699,794,884,994,1695,2143,2342,7060,7201,7689,7785,7933,8044,8748,9199,9396,	
mantenerse 6 518 6 121,161,357,7058,7120,7316,	
meses 27 518 27 118,180,270,362,1994,2008,2255,2417,4591,4679,4695,4775,4809,4846,4894,5000,5095,5148,5628,7055,7139,7229,7321,9049,9063,9309,9471,	
período 8 518 8 113,293,2250,4770,6697,7050,7252,9304,	
durante 28 518 28 111,291,358,992,1501,1581,1991,2005,2248,2951,2959,3311,3560,3576,3635,4587,4768,5091,5620,7048,7250,7317,8042,8552,8634,9046,9060,9302,	
corticosteroides 14 518 14 110,127,329,1409,1442,5015,5305,5340,5554,7047,7064,7288,8459,8492,	
microemulsión 7 518 7 108,132,256,5547,7045,7069,7215,	
ciclosporina 73 518 73 107,131,255,264,287,339,352,674,759,827,836,886,902,918,965,990,1331,1405,1732,2199,2245,2278,2296,2329,2337,2656,2666,2677,2689,2709,2733,2767,2778,4427,4596,4638,4717,4728,4758,4767,4824,4835,4878,4890,4914,4930,5443,5546,7044,7068,7214,7223,7246,7298,7311,7664,7750,7818,7827,7935,7951,7968,8015,8040,8381,8455,8785,9253,9299,9332,9350,9383,9391,	
combinación 10 518 10 105,350,1420,1444,3845,5438,7042,7309,8470,8494,	
inicialmente 2 518 2 103,7040,	
utilice 5 518 5 102,1318,6601,7039,8368,	
indica 1 518 1 5519,	
recomienda 27 518 27 98,610,628,888,1458,1512,1530,1602,1999,2365,2620,2770,2842,2908,2981,5914,7035,7601,7619,7895,7937,8508,8564,8582,8655,9054,9419,	
Se 32 518 32 97,797,1206,1493,1758,1837,1871,1998,2364,2769,2923,3549,3638,3978,3996,4076,4108,4540,5016,5869,5913,6439,7034,7788,7894,8256,8544,8811,8892,8926,9053,9418,	
lactosa 1 518 1 9569,	
renal 36 518 36 96,398,538,565,1464,2031,2204,2237,2363,2398,2474,4159,4217,4570,4631,4863,4998,5055,5296,5354,5474,5543,5831,6177,7033,7357,7498,7530,7556,8514,9086,9258,9291,9417,9452,9528,	
trasplante 17 518 17 95,206,273,365,1997,2473,4594,4997,5295,5542,5631,7032,7165,7232,9052,9451,9527,	
sometidos 9 518 9 92,1699,2028,3837,5967,6185,7029,8752,9083,	
inmunológico 7 518 7 91,1381,3907,4547,4643,7028,8431,	
riesgo 17 518 17 90,1380,1930,2017,2489,3552,3985,4068,4174,4546,4642,7027,8430,8855,8985,9072,9543,	
moderado 3 518 3 89,4551,7026,	
presentan 12 518 12 85,1378,1928,2208,2348,4144,7022,7722,8428,8983,9262,9402,	
normales 2 518 2 6096,6145,	
adultos 6 518 6 83,174,6031,7020,7133,7543,	
pacientes 130 518 130 82,332,368,424,492,509,525,535,562,580,592,604,623,662,713,730,1015,1135,1376,1507,1524,1560,1698,1772,1791,1833,1864,1926,1962,2014,2027,2052,2084,2105,2147,2206,2242,2275,2287,2325,2346,2393,2443,2469,3441,3649,3835,4041,4119,4142,4214,4226,4542,4565,4602,4640,4816,4827,4909,4922,4993,5024,5047,5108,5209,5237,5247,5293,5332,5423,5471,5540,5799,5813,5824,5965,6014,6023,6048,6098,6152,6354,7019,7291,7327,7382,7450,7469,7485,7495,7527,7542,7553,7571,7583,7595,7614,7652,7703,7720,7871,8065,8185,8426,8559,8576,8613,8751,8825,8844,8888,8919,8981,9017,9069,9082,9107,9140,9161,9203,9260,9296,9329,9341,9379,9400,9447,9497,9523,9572,	
órganos 4 518 4 80,3774,3858,7017,	
rechazo 9 518 9 78,4256,4535,4607,4746,5064,5259,5316,7015,	
profilaxis 8 518 8 76,1966,1982,2000,7013,9021,9037,9055,	
indicado 2 518 2 73,7010,	
está 4 518 4 72,6929,7009,7922,	
Rapamune 125 518 125 71,100,119,150,188,218,244,303,325,354,375,502,617,653,668,817,856,1028,1064,1079,1369,1438,1486,1505,1693,1775,1836,1856,2025,2055,2095,2118,2127,2145,2197,2247,2340,2391,2423,2467,2479,2772,2812,3007,3318,3447,3556,3574,3652,3666,3830,3843,4047,4066,4122,4136,4305,4351,4355,4562,4663,4711,4726,4819,4833,4888,4991,5103,5135,5188,5240,5283,5301,5364,5563,5792,5916,5938,6531,6561,6596,6779,6788,7008,7037,7056,7088,7147,7177,7203,7262,7284,7313,7334,7460,7523,7608,7643,7658,7808,7847,8078,8113,8128,8419,8488,8537,8556,8746,8828,8891,8911,9080,9110,9151,9174,9183,9201,9251,9301,9394,9445,9477,9521,9533,	
terapéuticas 3 518 3 70,3445,7007,	
pantalla 2 518 2 1954,9009,	
Indicaciones 2 518 2 69,7006,	
/ 5 518 5 2494,2498,3883,9548,9552,	
	4 2 518 2 67,7004,	
CLÍNICOS 2 518 2 66,7003,	
DATOS 3 518 3 65,6498,7002,	
fluidos 2 518 2 1814,8869,	
4 70 518 70 64,138,143,230,295,669,688,751,828,939,1126,1346,1348,1361,1362,1551,1595,1628,1658,1894,2448,2508,2636,2685,2757,2773,2852,2897,2900,2917,2990,3197,3198,3200,3202,3520,3670,3697,3976,4279,4319,4779,5041,5151,5165,5350,5698,6495,6655,7001,7076,7081,7189,7254,7659,7678,7742,7819,7989,8176,8396,8398,8411,8412,8603,8648,8681,8711,8949,9502,	
Huntercombe 1 518 1 6871,	
	Solución 1 518 1 62,	
FARMACÉUTICA 2 518 2 61,6982,	
FORMA 2 518 2 60,6981,	
debidos 1 518 1 6338,	
3 33 518 33 59,117,179,268,361,1035,1124,1164,1349,2007,2254,3030,3110,3223,3260,4556,4613,4934,5464,5583,5889,6189,6616,6980,7054,7138,7227,7320,8174,8214,8399,9062,9308,	
6 28 518 28 57,196,2414,2811,3033,3221,3521,4590,5093,5203,5578,5627,6496,6497,6528,6559,6560,6612,6613,6615,6647,6654,6702,6727,6728,6978,7155,9468,	
sección 5 518 5 56,4318,6494,6558,6977,	
mostraron 2 518 2 4850,6307,	
ver 6 518 6 55,236,320,6976,7195,7279,	
excipientes 5 518 5 54,1360,6504,6975,8410,	
completa 2 518 2 52,6973,	
lista 2 518 2 51,6972,	
abreviada 1 518 1 5382,	
linfoma 4 518 4 1640,3965,6283,8693,	
afroamericanos) 2 518 2 403,7362,	
consultar 2 518 2 49,6970,	
Para 6 518 6 48,813,4937,6817,6969,7804,	
Excipientes 2 518 2 47,6968,	
optimizarse 2 518 2 246,7205,	
sirolimus 124 518 124 46,413,449,473,532,587,635,679,720,796,907,914,929,936,980,1059,1118,1156,1200,1221,1284,1325,1343,1396,1519,1606,1730,1878,1903,2355,2563,2591,2597,2611,2617,2624,2649,2662,2672,2684,2740,2749,2795,2819,2847,2878,2895,2912,2930,2972,2985,3018,3059,3082,3104,3143,3169,3192,3232,3257,3340,3379,3393,3427,3457,3466,3504,3533,3597,3612,3623,3758,3995,4009,4151,4164,4202,4269,4438,4511,5397,5436,5461,5521,5536,5637,5821,5866,5881,6070,6116,6169,6471,6967,7371,7407,7431,7492,7578,7626,7669,7710,7787,7956,7964,7979,7986,8030,8108,8168,8206,8250,8271,8334,8375,8393,8446,8571,8659,8783,8933,8958,9409,9565,	
mg 29 518 29 44,197,210,666,1086,1095,2660,2670,2682,2806,2947,2955,3002,3010,3261,3265,4303,5561,5669,5693,6953,6965,7156,7169,7656,7891,7893,8135,8144,	
contiene 3 518 3 42,6564,6963,	
ml 3 518 3 41,6717,6810,	
	Cada 2 518 2 40,6961,	
CUANTITATIVA 2 518 2 39,6960,	
Y 2 518 2 38,6959,	
CUALITATIVA 2 518 2 37,6958,	
COMPOSICIÓN 2 518 2 36,6957,	
2 46 518 46 35,115,139,144,209,409,665,953,968,1112,1552,1596,2725,2935,3109,3114,3115,3203,5076,5169,5234,5288,5386,5420,5560,5576,5579,5586,5650,5668,5784,6518,6529,6620,6956,7052,7077,7082,7168,7655,7902,8003,8018,8162,8604,8649,	
conjuntivo 1 518 1 3941,	
oral 20 518 20 34,63,155,194,2809,2945,2998,3005,3084,3171,3284,3310,5396,5868,6563,6598,7093,7153,7462,7881,	
solución 11 518 11 33,2808,3004,3083,3170,5395,5564,6562,6597,7461,7880,	
mg/ml 1 518 1 32,	
	Rapamune 2 518 2 30,6951,	
MEDICAMENTO 3 518 3 29,4369,6950,	
interrumpirse 6 518 6 134,289,374,7071,7248,7333,	
NOMBRE 2 518 2 27,6948,	
PRODUCTO 1 518 1 24,	
DEL 4 518 4 23,28,6921,6949,	
grupo 11 518 11 4709,4722,4753,4762,4829,4874,4886,5131,5184,5192,6044,	
CARACTERÍSTICAS 1 518 1 22,	
LAS 1 518 1 21,	
DE 9 518 9 20,4367,6863,6866,6883,6885,6890,6894,6918,	
RESUMEN 1 518 1 19,	
O 1 518 1 18,	
absorción 5 518 5 2558,2647,2873,3093,3180,	
TÉCNICA 1 518 1 17,	
voriconazol 5 518 5 1615,2582,2944,2987,8668,	
FICHA 1 518 1 16,	
ocasiones 2 518 2 1898,8953,	
tuvo 2 518 2 675,7665,	
información 10 518 10 13,390,479,1267,1429,6924,7349,7437,8317,8479,	
Toda 1 518 1 11,	
medicamento 6 518 6 10,15,1580,6739,6928,8633,	
Basica 1 518 1 8,	
	Información 1 518 1 7,	
ORAL 1 518 1 6,	
SOLUCION 1 518 1 5,	
respectivamente) 2 518 2 4781,4936,	
BOTELLA 1 518 1 4,	
atención 2 518 2 802,7793,	
1 35 518 35 3,25,26,31,43,58,68,1385,2899,2952,3027,3029,3032,3111,3112,3130,3199,3220,3222,3225,4371,5074,5232,5409,5769,6501,6947,6952,6964,6979,6998,7005,7900,8435,8520,	
parte 3 518 3 1858,5767,8913,	
60ML 1 518 1 2,	
causal 1 518 1 3825,	
5MG/5ML 1 518 1 1,	
RAPAMUNE 1 518 1 0,	
